Form 4 for HLF HERBALIFE LTD.
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0000950170-25-027124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-25 | 2025-02-25 | HLF | Hicks Troy | COO | F - Tax | $8.29 | -1,548 | 56.4K | -3% | -$12.8K |
| D | 2025-02-25 | 2025-02-21 | HLF | Hicks Troy | COO | A - Grant | $0.00 | +52.4K | 52.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | F | D | 1,548 | $8.29 | 56,447 | D | — | — | (F1) Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022. (F2) Balance includes shares purchased through the Issuer's Employee Stock Purchase Plan since the Reporting Person's last Form 3 filing on June 10, 2024. |
| 2 | Derivative | Stock Appreciation Rights | 2025-02-21 | A | A | 52,445 | $0.00 | 52,445 | D | $8.31 · — to 2035-02-21 | 52,445 Common Stock | (F3) Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 21, 2026, February 21, 2027, and February 21, 2028, subject to continued service through such date. |